Bertrand Loy - Aug 22, 2022 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role
Director
Signature
/s/ Bertrand Loy
Stock symbol
HBIO
Transactions as of
Aug 22, 2022
Transactions value $
$44,414
Form type
4
Date filed
8/24/2022, 04:06 PM
Previous filing
Aug 22, 2022
Next filing
Aug 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HBIO Common Stock Purchase $15.5K +4.92K +1.4% $3.16 356K Aug 22, 2022 Direct F1, F2
transaction HBIO Common Stock Purchase $28.9K +8.94K +2.51% $3.23 365K Aug 23, 2022 Direct F3, F4
holding HBIO Common Stock 68.5K Aug 22, 2022 by The BZH Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $3.13 to $3.22, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Includes (a) the shares purchased in the transaction described in footnote (1) above, (b) 47,493 restricted stock units that will vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders, immediately prior to the commencement of such meeting, and (ii) May 24, 2023, and (c) 303,475 shares of common stock held by the Reporting Person.
F3 This transaction was executed in multiple trades at prices ranging from $3.195 to $3.26, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 Includes (a) the shares described in footnote (2) above and (b) the shares purchased in the transaction described in footnote (3) above.